RXi Data Shows Long-Term CNS Delivery of
siRNA Can Slow ALS Progression in Mouse
[April 17, 2008]
By Doug Macron
The findings support RXi’s belief that long-term administration of RNAi compounds to the CNS may be able to treat familial ALS. However, the company has yet to move the program into its formal drug-development pipeline.
http://www.rnainews.com/issues/6_16/.../146356-1.html